Crystal-induced inflammatory arthritis affecting multiple joint sites simultaneously, where the specific crystal type is identified but does not fall under gout or calcium pyrophosphate deposition (CPPD) disease categories.

Documentation tips

What should appear in the chart to support M11.89.

Source · Editorial brief grounded in 5 cited references ↓

• Provider must name the specific crystal type (e.g., calcium hydroxyapatite, calcium oxalate) — 'crystal arthropathy' without crystal identification does not support M11.89 over an unspecified code.
• Document each affected joint by name and side; 'multiple sites' requires at least two distinct anatomical locations explicitly noted in the encounter.
• If synovial fluid analysis or imaging (e.g., ultrasound showing hyperechoic deposits, radiograph showing calcific deposits) confirms crystal type, reference the finding directly in the assessment/plan.
• Distinguish crystal type in the diagnosis: monosodium urate = gout (M10); calcium pyrophosphate = M11.1x/M11.2x; all others meeting polyarticular criteria = M11.89.
• For inpatient claims, document comorbidities thoroughly — MCC vs. no-MCC status determines MS-DRG assignment and reimbursement tier.

Related CPT procedures

Procedure codes commonly billed with M11.89. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M11.89 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Coding M11.89 when only one joint is involved — use the single-site M11.8x code with the appropriate site character instead.
• Using M11.89 for gout flares involving multiple joints — gout maps exclusively to M10.x regardless of how many joints are affected.
• Selecting M11.89 when the provider documents calcium pyrophosphate (pseudogout) — that belongs to M11.1x (familial CPPD) or M11.2x (other CPPD), not M11.89.
• Assigning M11.89 based on 'crystal arthropathy' documentation alone without a specified crystal type — query the provider or use M11.9 (unspecified crystal arthropathy) if the crystal is not identified.
• Omitting additional codes for associated conditions such as renal failure or hyperparathyroidism that may be driving crystal deposition — code underlying metabolic causes separately when documented.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M11.8 (laterality / anatomic variants).